Search hospitals > Pennsylvania > York
WellSpan Health-York Hospital
Claim this profileYork, Pennsylvania 17403
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
263 reported clinical trials
18 medical researchers
Summary
WellSpan Health-York Hospital is a medical facility located in York, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. WellSpan Health-York Hospital is involved with conducting 263 clinical trials across 336 conditions. There are 18 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and William Nicholson.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Amit B. ShahWellSpan Health-York Cancer Center4 years of reported clinical research
Studies Prostate Cancer
Studies Breast Cancer
23 reported clinical trials
65 drugs studied
Chanh T. HuynhAdams Cancer Center2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
38 drugs studied
Dan SotirescuEphrata Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
28 drugs studied
William NicholsonEmory University Hospital4 years of reported clinical research
Studies Coronary Artery Disease
Studies Von Willebrand Disease
10 reported clinical trials
11 drugs studied
Clinical Trials running at WellSpan Health-York Hospital
Lung Cancer
Breast Cancer
Stroke
Heart Failure
Prostate Cancer
Atrial Fibrillation
Pancreatic Cancer
Cancer
Breast cancer
Non-Small Cell Lung Cancer
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WellSpan Health-York Hospital?
WellSpan Health-York Hospital is a medical facility located in York, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. WellSpan Health-York Hospital is involved with conducting 263 clinical trials across 336 conditions. There are 18 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and William Nicholson.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.